FDA Advisory Committees - FDA Center for Drug Evaluation and Research (CDER) - Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC)

Upcoming Meetings


Past Meetings

Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC)

EMDAC reviews and evaluates data concerning the safety and effectiveness of marketed and investigational human drug products for use in the treatment of endocrine and metabolic disorders, and makes appropriate recommendations to the Commissioner of Food and Drugs.

FDA Committee Page